ARCELLX INC reports a Return on Equity (ROE) of -56.90%.

What is ACLX's dividend yield?

ARCELLX INC offers a dividend yield of 0.00%.

What is ACLX's Deepscope Quality Score?

Deepscope rates ACLX's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ACLX?

Deepscope's AI Timing Score for ACLX is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ACLX belong to?

ARCELLX INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu ACLX (NASDAQ) | ARCELLX INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-05-15 | FS: 2025-12-31)

ACLX

ARCELLX INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 94

USD 115.07

0.00 (0.00%) Day Change

Watchlist Portfolio Compare Chart

0.02

D/E

-56.9%

ROE

-37.9%

ROA

0.00%

Div Yield

ARCELLX INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 115.07 Price 0.00 (0.00%) Day Change	NEWS SCORE: 94

ACLX Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) nhưng Thời điểm mua ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...

Yếu tố Chất lượng

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	94
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	115.07
PBV / Sector	16.10 / 4.91
Earning Per Share	-4.07

PE / Sector	N/A / 18.34
PEG or PE/Growth / Sector	N/A / 0.61
Average 1M Daily Value	229.94 M GREAT
Average 1W Daily Value	684.40 M

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-1,027.25 / 468.85
NPM Average (%) / Sector	-561.04 / -1,531.69
NPM Change Average (%) / Sector	298.06 / 5,028.65 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-37.90 / 31.69
ROA Average (%) / Sector	-30.42 / -353.18
ROA Change Average (%) / Sector	47.19 / 5,214.65 GREAT
ROE (%) / Sector	-56.90 / 10.58
ROE Average (%) / Sector	-46.78 / 27.64
ROE Change Average (%) / Sector	39.65 / 2,048.88 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.15

Chi tiết đăng ký

Analyze Date	2026-06-13 11:13:46
Symbol	ACLX
Name	ARCELLX INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	58.51 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	6,479.08 / 9,034.83

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 800 Bridge Parkway, Redwood City, CA, United States, 94065

Phone: 240 327 0630

Website: https://www.arcellx.com

Employees: 209

Sector: Healthcare >> Biotechnology

Description: Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). It also develops ACLX-001, a product candidate in Phase 1 clinical trials targeting BCMA to treat rrMM; and ACLX-002, which is in Phase 1 clinical trials that targets CD123 for treating relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). In addition, the company preclinical product includes ACLX-004 for the treatment of AML and MDS. Further, the company focuses on the development of product candidates for solid tumor programs. It has a strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize nito-cel and next-generation autologous and non-autologous CAR-T cell therapy products. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Redwood City, California. As of April 28, 2026, Arcellx, Inc. operates as a subsidiary of Gilead Sciences, Inc.